Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.0200 (-2.11%) ($5.8800 - $6.2000) on Mon. Jan. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 62 | Latest Price | $6.0200(-2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.3% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(66%) ARKK(63%) XBI(63%) IBB(58%) IPO(56%) | Factors Impacting CGEN price | CGEN will decline at least -1.805% in a week (0% probabilities). VXX(-37%) VIXM(-33%) UUP(-11%) TLT(-4%) TBT(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
5 Day Moving Average | $6.07(-0.82%) | 10 Day Moving Average | $6.03(-0.17%) | 20 Day Moving Average | $5.93(1.52%) | To recent high | -2.9% | To recent low | 20.2% | Market Cap | $498m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |